1
2
3

Information List

C14 Marked Key Compound Preparation Technology Conquer-China Chemical News (Sinochem New Net)

2019-04-15

C14 Marked Key Compound Preparation Technology Conquer Author: Wu Ban Source: China Chemical News March 26, 2019 Website; http://www.ccin.com.cn/detail/c18866c562abbac1ba4154d0ca9e214c/news中化新网讯3月20日,江苏省江阴国家高新区发布了一项重点创新成果:该区无锡贝塔医药科技有限公司攻克了C14标记关键化合物制备和标记技术,成功开发出用于胃幽门螺旋杆菌感染诊断

Overcome the technical difficulties in the preparation of carbon -14 labeled key compounds-Economic Daily, China Economic Net

2019-04-15

Technical Difficulties in Preparation of Carbon -14 Marked Key Compounds Overcome 2019-03-2109:31 Source: Science and Technology Daily Website: http://tech.ce.cn/news/201903/21/t20190321_31719326.shtml

China Overcomes Technical Difficulties in Preparation and Labeling of Key Carbon -14 Labeling Compounds_Sohu Net-News

2019-04-15

Website: http://www.sohu.com/a/302811457_115479我国攻克碳-14标记关键化合物制备与标记技术难关科技日报3月20日消息,3月20日,江苏省江阴国家高新区发布了一项重点创新成果:该区无锡贝塔医药科技有限公司研发团队经过10年努力,攻克了碳-14标记关键化合物制备和标记技术难关,并集成应用多项现代先进技术,成功开发出用于胃幽门螺旋杆菌感染诊断用的关键紧缺原料药尿素-

Wuxi Beta conquers the key technology of isotope labeling to help new drug research and development-Xinhua-Jiangsu Channel.

2019-04-15

Wuxi Beta Conquers Key Technology of Isotope Labeling to Help New Drug Research and Development March 21, 2019 11:10:13 Source: Wuxi Beta Pharmaceutical Technology Co., Ltd. Website: http://www.js.xinhuanet.com/2019-03/21/c_1124263801.htm近日,位于江苏江阴高新区的无锡贝塔医药科技有限公司与四川科伦药物研究院签订科技服务合作协议 。 The head of the hospital's new drug research and development department recognized Wuxi Beta's radioisotope labeling work and believed that Wuxi Beta 2

Wuxi Beta Conquers Key Technology of Isotope Labeling to Help New Drug Research and Development-Torch Center of Ministry of Science and Technology

2019-04-15

Jiangyin High-tech Zone: Wuxi Beta Conquers Key Technology of Isotope Labeling to Help New Drug Research and Development March 26, 2019 Source: China High-tech Industry Herald Website: http://www.ctp.gov.cn/kjb/dfdt/201903/bde017961f1044aa833792f9e823ef02.shtml近日获悉,江阴高新区企业无锡贝塔医药科技有限公司与四川科伦药物研究院签订科技服务合作协议 。 The new drug research and development department of Sichuan Kelun Pharmaceutical Research Institute is negative.

Overcome the technical difficulties in the preparation of carbon -14 labeled key compounds-the website of the Chinese Academy of Sciences.

2019-04-15

Technical Difficulties in Preparation of Carbon -14 Marked Key Compounds Overcome Time: 2019-03-2223:36 Author: Unknown Source: Unknown Click: 875 Times Website: http://guoshizhong.com/huaxuekexue/2019/0322/18856.html科江阴3月20日电3月20日,江苏省江阴国家高新区发布了一项重点创新成果:该区无锡贝塔医药科技有限公司研发团队经过10年努力,攻克了碳-14标记关键化合物制备和标记技术难关,

Carbon -14 Marked Key Compound Preparation Technology Difficulties Overcome-Third Edition-Science and Technology Daily

2019-04-15

Technical Difficulties in Preparation of Carbon -14 Labeled Key Compounds Overcome 2019-03-2100:00:00 Source: Science and Technology Daily Author: Reporter Guo Guozhong Science and Technology Daily Jiangyin, March 20 (Reporter Guo Guozhong Correspondent Shen Wei Guo Yin Qingxi) On March 20, Jiangyin National High-tech Zone in Jiangsu Province released a key innovation: After 10 years of hard work, the research and development team of Wuxi Beta Pharmaceutical Technology Co., Ltd. in the zone, overcoming the technical difficulties in the preparation and labeling of key compounds labeled with carbon -14, and integrating the application of a number of modern advanced technologies, we have successfully developed a technology for the treatment of gastric cancer.

Wuxi Beta and Shenyang Research Institute of Chemical Industry to establish a cooperative relationship

2018-10-25

On August 15, 2018, Wuxi Beta Pharmaceutical Technology Co., Ltd. and the Safety Evaluation Center of Shenyang Research Institute of Chemical Industry signed a strategic cooperation agreement to complement each other's advantages and do their best to cooperate in the development of C14 and tritium labeling of pesticides and the pharmaceutical generation of animals and plants in China Research, actively promote China's agricultural development and environmental protection.

Wuxi Beta establishes partnership with American CIL

2018-10-25

On July 18, 2018, Wuxi Beta Pharmaceutical Technology Co., Ltd. signed a supply agreement with CambridgeIsotopeLaboratories,Inc.(CIL) to jointly develop the industrialization of isotope labeled products such as urea-13C and promote the popularization of gastric Helicobacter pylori detection in China.

Wuxi Beta establishes cooperative relationship with China Academy of Engineering Physics

2018-10-25

On January 31, 2018, Wuxi Beta Pharmaceutical Technology Co., Ltd. and the Second Institute of China Academy of Engineering Physics signed a memorandum of cooperation to cooperate in the development of my country's C14 source materials and tracer technology, promote military-civilian integration, and nuclear technology in the medical and medical fields Application to benefit human health.

< 12345 >